Tagged: AI in pharma

Drug development faces a significant challenge: 28% of medications leave the US market because of unexpected heart-related side effects. This stark reality, combined with 400 million people worldwide affected by rare diseases, makes pharmaceutical collaboration more vital than ever. Pharmaceutical companies are reshaping their approach...